Close
What would you like to look for?

8 August 2018

TransLink Capital, a leading US venture capital fund, has invested as lead investor in the Series A financing round of aktiia SA, Neuchâtel, a Swiss startup active in optical blood pressure monitoring.
 
VISCHER advised TransLink Capital as Swiss counsel in this financing round. The VISCHER team included Christian Wyss (Partner, Corporate/M&A) and Gian-Andrea Caprez (Managing Associate, Corporate/M&A).

Categories: Life Sciences, Pharma, Biotech, Mergers & Acquisitions, Private Equity & Venture Capital, Startup Desk, Deals & Cases

Authors